Page last updated: 2024-11-02

oxophenylarsine and Uterine Cervical Neoplasms

oxophenylarsine has been researched along with Uterine Cervical Neoplasms in 1 studies

oxophenylarsine: inhibits protein-tyrosine-phosphatase
phenylarsine oxide : An arsine oxide derived from phenylarsine.

Uterine Cervical Neoplasms: Tumors or cancer of the UTERINE CERVIX.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, HL1
Park, MH1
Hong, JE1
Kim, DH1
Kim, JY1
Seo, HO1
Han, SB1
Yoon, JH1
Lee, WH1
Song, HS1
Lee, JI1
Lee, US1
Song, MJ1
Hong, JT1

Other Studies

1 other study available for oxophenylarsine and Uterine Cervical Neoplasms

ArticleYear
Inhibitory effect of snake venom toxin on NF-κB activity prevents human cervical cancer cell growth via increase of death receptor 3 and 5 expression.
    Archives of toxicology, 2016, Volume: 90, Issue:2

    Topics: Animals; Apoptosis; Arsenicals; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female;

2016